我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

152例糖尿病肾病的证候及疗效分析(PDF)

《云南中医学院学报》[ISSN:1000-2723/CN:53-1048/R]

期数:
2010年06期
页码:
6-9
栏目:
临床研究
出版日期:
2010-12-20

文章信息/Info

Title:
152 Patienss with Symptoms of Diabetic Nephropathy and Clinical Analysis
作者:
吉勤李红帅
云南中医学院第一附属医院,云南昆明650021
Author(s):
JI QingLI Hong-shuai
The First Affiliated Hospital of Yunnan University of TCM,Kunming Yunnan 650021,China
关键词:
糖尿病肾病血瘀证中西医结合治疗
Keywords:
diabetic nephropathyblood stasisintegrative medicine
分类号:
R241
DOI:
-
文献标识码:
A
摘要:
目的:总结糖尿病肾病(DN)的诊治方法及总体疗效。方法:通过回顾我科近5年152例住院及门诊DN患者的诊治过程,归纳其证型分布和治疗方案特点,研究治疗方案的有效性及不足之处。结果:(1)DN患者UAER组以气阴两虚证为主,临床蛋白尿期以脾肾气/阳虚证为主,而ESRD组而证型较为分散,而血瘀证分布于各型各期且最多,约占6051%.(2)经采用西医规范治疗,配合中医辨证论治及活血化瘀中成药治疗1月时,HBAlc、CRP、TG及部分sCr、cCr均得到改善;治疗2月时mALB、Alb明显下降。结论:(1)血瘀证是DN疾病中最常见的证型。(2)短期治疗可以改善症状,并整体改善患者病情。(3)尿mAL、BAlb在治疗2月时明显下降。
Abstract:
Objective:To summarize the diagnosis,treatment and overall efficacy of diabetic nephropathy(DN).Methods:Through a review of 152 cases on DN diagnosis and treatment of outpatients or inpatients of the past 5 years,summarized pattern distribution and the characteristics of their teatment,study the treatments effectiveness and deficiency.Results:(1)Qi and Yin deficiency pattern is main in UAER group,spleen and kidney Qi/Yang Deficiency-based pattern is main in clinical proteinuria group,and the patterns are dispersed in ESRD group,however,blood stasis distributed in all kinds of types and groups,it is 6051 percent of the total number of DN patients.(2)Hemoglobin(HBAIC),C-reactive protein(CRP),triglyceride(TG),and some renal function(sCr,cCr)were improved a month later,glycosylated urinary albumin(mALB)and 24 hour urinary protein(ALb)decreased obviously after two months by the treatment with Western medicine,traditional Chinese medicine,and Chinese patent medicine.Conclusion:(1)Blood Stasis is the most common pattern of DN.(2)Short-term treatment can improve symptoms and the overall Status.(3)mALB,Alb can be significantly reduced after 2-month treatment.

参考文献/References

[1]Rossing P.Diabetic nephropothy:worldwild epid emic and effectsof current treatment on natural history[J].Curr Diab Rep,2006,6(6):479-483.
[2]崔红云,王宗谦,王准证.339例慢性肾衰竭的病因分析[J].医学信息手术学分册.2008,(21)11:982-998.
[3]中国中医药学会消渴病专业委员会.消渴病(糖尿病)中医分期辨证与疗效评定标准[J].中国医药学报,1993,8(3):54.
[4]郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:233-234.
[5]巩振东,李翠娟,苗彦霞,等.中医药治疗糖尿病肾病用药规律分析[J].陕西中医学院学报,2009,32(6):97-98.
[6]滕守峰,张亚文.尿微量蛋白三项在糖尿病肾损伤早期诊断中的价值[J].中国误诊学杂志,2009,9(34):8405.
[7]李萍,李艳英.糖尿病心血管病变诊治进展[J].山东医药,2009,49(37):105-107.
[8]林善锬.糖尿病肾病[J].中华内科杂志,2005,44(3):229-231.
[9]钱红霞,李新胜,黄倩.2型糖尿病患者尿微量白蛋白与血脂的关系[J].中国误诊学杂志,2009,9(34):8358.
[10]胡敏,王英.2型糖尿病肾病病人血脂代谢的分析[J].国际医药卫生导报,2005,11(18):34236.
[11]曹彤,李胜男,肖振忠.糖尿病肾病患者炎症相关因子水平检测的临床意义[J].中华保健医学杂志,2009,11,(5)356-358.
[12]Stehouwer CD,Gall MA,Twisk JW,et al.Increased ufinary albumin“exeretion,endothelial dysfunction,and chronic low-grade inflammation in type 2 diabetes”:progressive,interrelated,and independently associated with risk of death[J].Diabetes,2002,51(4):1157-75.
[13]曾卫阳.贝那普利联合缬沙坦对糖尿病肾病患者血清MCP-1及hs-CRP的影响[J].医学临床研究,2009,26(10):1865-1867.

备注/Memo

备注/Memo:
收稿日期:2010—08—12修回日期:2010—09—10 作者简介:吉勤(1958~),女,云南楚雄人,教授,硕士生导师。主要从事中医肾病临床,教学、科研等工作。
更新日期/Last Update: 2011-04-06